Gilead Sciences, Inc. SEC filings GILD

Gilead Sciences, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Apr 4, 2018. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Gilead Sciences, Inc. SEC filings
Form Description Filed Period
13F-HR Filing Nov 6, 2026 Sep 30, 2026
144 Notice of proposed sale Nov 4, 2026 —
4 Insider transaction Nov 2, 2026 Oct 30, 2026
144 Notice of proposed sale Oct 30, 2026 —
4 Insider transaction Oct 16, 2026 Oct 15, 2026
4 Insider transaction Oct 16, 2026 Oct 15, 2026
144 Notice of proposed sale Oct 15, 2026 —
144 Notice of proposed sale Oct 15, 2026 —
4 Insider transaction Oct 2, 2026 Oct 1, 2026
4 Insider transaction Sep 23, 2026 Sep 22, 2026
4 Insider transaction Sep 16, 2026 Sep 15, 2026
4 Insider transaction Sep 16, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
4 Insider transaction Sep 11, 2026 Sep 10, 2026
4 Insider transaction Sep 11, 2026 Sep 10, 2026
4 Insider transaction Sep 11, 2026 Sep 10, 2026
4 Insider transaction Sep 11, 2026 Sep 10, 2026
4 Insider transaction Sep 11, 2026 Sep 10, 2026
4 Insider transaction Sep 2, 2026 Sep 1, 2026
4 Insider transaction Aug 27, 2026 Aug 26, 2026
144 Notice of proposed sale Aug 26, 2026 —
4 Insider transaction Aug 21, 2026 Aug 20, 2026
144 Notice of proposed sale Aug 20, 2026 —
4 Insider transaction Aug 18, 2026 Aug 17, 2026
4 Insider transaction Aug 18, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 17, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
4 Insider transaction Aug 11, 2026 Aug 10, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 7, 2026 —
4 Insider transaction Aug 4, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 3, 2026 —
13F-HR Filing Aug 3, 2026 Jun 30, 2026
4 Insider transaction Jul 16, 2026 Jul 15, 2026
4 Insider transaction Jul 16, 2026 Jul 15, 2026
144 Notice of proposed sale Jul 15, 2026 —
144 Notice of proposed sale Jul 15, 2026 —
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 27, 2026 May 26, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 27, 2026 —
4 Insider transaction May 18, 2026 May 15, 2026
4 Insider transaction May 18, 2026 May 15, 2026
144 Notice of proposed sale May 15, 2026 —
144 Notice of proposed sale May 15, 2026 —
13F-HR Filing May 8, 2026 Mar 31, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
4 Insider transaction Apr 29, 2026 Apr 28, 2026
144 Notice of proposed sale Apr 28, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 28, 2026 —
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
144 Notice of proposed sale Apr 15, 2026 —
144 Notice of proposed sale Apr 15, 2026 —
4 Insider transaction Mar 30, 2026 Mar 27, 2026
144 Notice of proposed sale Mar 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 17, 2026 Mar 16, 2026
4 Insider transaction Mar 17, 2026 Mar 16, 2026
144 Notice of proposed sale Mar 16, 2026 —
144 Notice of proposed sale Mar 16, 2026 —
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 2, 2026 Feb 27, 2026
4 Insider transaction Mar 2, 2026 Feb 27, 2026
4 Insider transaction Mar 2, 2026 Feb 27, 2026
4 Insider transaction Mar 2, 2026 Feb 27, 2026
4 Insider transaction Mar 2, 2026 Feb 27, 2026
144 Notice of proposed sale Feb 27, 2026 —
SCHEDULE 13D Ownership over 5% (active) Feb 23, 2026 —
4 Insider transaction Feb 18, 2026 Feb 17, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
4 Insider transaction Feb 17, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
3 Initial insider ownership Feb 12, 2026 Feb 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
13F-HR Filing Feb 12, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
4 Insider transaction Feb 6, 2026 Feb 5, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
144 Notice of proposed sale Feb 5, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2026 —
4 Insider transaction Jan 29, 2026 Jan 28, 2026
144 Notice of proposed sale Jan 28, 2026 —
4 Insider transaction Jan 26, 2026 Jan 23, 2026
144 Notice of proposed sale Jan 23, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
4 Insider transaction Jan 21, 2026 Jan 20, 2026
144 Notice of proposed sale Jan 20, 2026 —
4 Insider transaction Jan 16, 2026 Jan 15, 2026
4 Insider transaction Jan 16, 2026 Jan 15, 2026
144 Notice of proposed sale Jan 15, 2026 —
144 Notice of proposed sale Jan 15, 2026 —
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Dec 30, 2025 Dec 29, 2025
144 Notice of proposed sale Dec 29, 2025 —
4 Insider transaction Dec 16, 2025 Dec 15, 2025
4 Insider transaction Dec 16, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 11, 2025 Dec 10, 2025
4 Insider transaction Dec 11, 2025 Dec 10, 2025
4 Insider transaction Dec 11, 2025 Dec 10, 2025
4 Insider transaction Dec 1, 2025 Nov 28, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Dec 1, 2025 Nov 28, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
144 Notice of proposed sale Nov 28, 2025 —
144 Notice of proposed sale Nov 28, 2025 —
144 Notice of proposed sale Nov 26, 2025 —
4 Insider transaction Nov 18, 2025 Nov 17, 2025
4 Insider transaction Nov 18, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
4 Insider transaction Nov 13, 2025 Nov 12, 2025
144 Notice of proposed sale Nov 13, 2025 —
13F-HR Filing Nov 13, 2025 Sep 30, 2025
144 Notice of proposed sale Nov 12, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 5, 2025 —
4 Insider transaction Oct 29, 2025 Oct 28, 2025
144 Notice of proposed sale Oct 28, 2025 —
4 Insider transaction Oct 27, 2025 Oct 25, 2025
4 Insider transaction Oct 16, 2025 Oct 15, 2025
4 Insider transaction Oct 16, 2025 Oct 15, 2025
144 Notice of proposed sale Oct 15, 2025 —
144 Notice of proposed sale Oct 15, 2025 —
4 Insider transaction Oct 3, 2025 Aug 8, 2025
4 Insider transaction Sep 30, 2025 Sep 29, 2025
144 Notice of proposed sale Sep 29, 2025 —
4 Insider transaction Sep 23, 2025 Sep 22, 2025
3 Initial insider ownership Sep 23, 2025 Sep 22, 2025
4 Insider transaction Sep 16, 2025 Sep 15, 2025
4 Insider transaction Sep 16, 2025 Sep 15, 2025
144 Notice of proposed sale Sep 15, 2025 —
144 Notice of proposed sale Sep 15, 2025 —
4 Insider transaction Sep 11, 2025 Sep 10, 2025
4 Insider transaction Sep 11, 2025 Sep 10, 2025
4 Insider transaction Sep 11, 2025 Sep 10, 2025
4 Insider transaction Sep 11, 2025 Sep 10, 2025
4 Insider transaction Sep 11, 2025 Sep 10, 2025
4 Insider transaction Aug 29, 2025 Aug 28, 2025
144 Notice of proposed sale Aug 28, 2025 —
4 Insider transaction Aug 18, 2025 Aug 15, 2025
4 Insider transaction Aug 18, 2025 Aug 15, 2025
144 Notice of proposed sale Aug 15, 2025 —
144 Notice of proposed sale Aug 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
13F-HR Filing Aug 14, 2025 Jun 30, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 12, 2025 —
4 Insider transaction Jul 29, 2025 Jul 28, 2025
4 Insider transaction Jul 28, 2025 Jul 25, 2025
144 Notice of proposed sale Jul 28, 2025 —
4 Insider transaction Jul 16, 2025 Jul 15, 2025
4 Insider transaction Jul 16, 2025 Jul 15, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 15, 2025 —
144 Notice of proposed sale Jul 15, 2025 —
144 Notice of proposed sale Jul 15, 2025 —
4 Insider transaction Jul 15, 2025 Jul 14, 2025
144 Notice of proposed sale Jul 14, 2025 —
4 Insider transaction Jul 1, 2025 Jun 30, 2025
144 Notice of proposed sale Jun 30, 2025 —
4 Insider transaction Jun 17, 2025 Jun 16, 2025
4 Insider transaction Jun 17, 2025 Jun 16, 2025
144 Notice of proposed sale Jun 16, 2025 —
144 Notice of proposed sale Jun 16, 2025 —
4 Insider transaction Jun 11, 2025 Jun 10, 2025
4 Insider transaction Jun 11, 2025 Jun 10, 2025
4 Insider transaction Jun 11, 2025 Jun 10, 2025
4 Insider transaction Jun 11, 2025 Jun 10, 2025
4 Insider transaction Jun 11, 2025 Jun 10, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
144 Notice of proposed sale May 30, 2025 —
4 Insider transaction May 23, 2025 May 22, 2025
144 Notice of proposed sale May 22, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
GILD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Foster City, CA
SEC filer status
Large accelerated filer
SEC CIK
882095
Former names
GILEAD SCIENCES INC (until Feb 17, 2022)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.